2017-11-27 18:42:03 UTC

Putting Patients First: Digital Health Tools to Empower IBD Patients


Jan. 18, 2017, 6–7:30 p.m.


ARIA Hotel

Las Vegas, NV


Join AGA, the Cedars-Sinai IBD Center, the Cedars-Sinai Center for Outcomes Research and Education (CS-CORE) in a free, first-of-its-kind, “interactive didactic” continuing medical education (CME) symposium taking place at Crohn’s & Colitis Congress™ on January 18.

Patients with inflammatory bowel disease (IBD) spend most of their lives far away from a clinic examination room. If gastroenterologists are truly going to engage patient’s in their care, they must find ways to reach out to where their patients live, work, and play. Discover how advances in digital health can help you monitor and support patients remotely and dynamically, improve face-to-face care, and drive clinical decisions through shared decision-making.

The course is free. To register, visit gastro.org/ibdsymposium.

Who Should Take this Course

IBD professionals, including gastroenterologists, nurse practitioners, physician assistants and nurses. 


  1. Discover how virtual reality (VR) can be used as an adjuvant digital therapy to help IBD patients.
  2. Learn about the landscape and effectiveness of mobile health (mHealth) apps and decision aids for IBD self-management.
  3. Review IBD&me (ibdandme.org), a novel online, immersive, and interactive conjoint analysis-based decision aid that supports patients in selecting a biologic that is congruent with their preferences and beliefs.

About the Instructors

Course Director:
Brennan M.R. Spiegel, MD, MSHS, Cedars-Sinai Medical Center

Co-Course Director:
hristopher V. Almario, MD, MSHPM, Cedars-Sinai Medical Center

Gil Melmed, MD, MS, Cedars-Sinai Medical Center

Contact Information

To register, visit gastro.org/ibdymposium.

Any questions, please contact Sandra Megally Amos, director of education, at smegally@gastro.org.

More on Crohn's Disease

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Get Your Questions Answered on Biosimilar Therapies

Dec. 7, 2017

Join inflammatory bowel disease (IBD) experts on Dec. 11, 2017, 8-8:45 p.m. ET, for a free webinar on biosimilar therapies.

Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months

Oct. 22, 2017

We investigated whether serum trough levels of vedolizumab, during the induction phase can determine whether patients need additional doses within 6 months.